<rss version="2.0"><channel><title>BioSpace.com News</title><link>http://www.biospace.com</link><generator>BioSpace RSS Generator</generator><lastBuildDate>Wed, 22 May 2013 21:40:42 GMT</lastBuildDate><ttl>20</ttl><image><url>http://rss.biospace.com/images/BSPLogo.gif</url><title>BioSpace.com</title><link>http://www.BioSpace.com/news.aspx?SectionId=1</link></image><copyright>Copyright (C) 2011</copyright><item><title>New Diagnostics Solutions From Welch Allyn to Help Improve Patient Safety, Reduce Risk for Facilities  </title><link>http://www.businesswire.com/portal/site/biospace2/index.jsp?ndmViewId=news_view&amp;newsId=20130520005890&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;BOSTON--(BUSINESS WIRE)--National Teaching Institute &amp; Critical Care Exposition: Welch Allyn, a leading medical diagnostic device company that specializes in helping clinicians improve patient outcomes, will...</description><pubDate>Mon, 20 May 2013 12:00:00 AM GMT</pubDate></item><item><title>NinePoint Medical Announces U.S. Commercial Availability of the NvisionVLE&amp;#0153; Imaging System  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130516005632&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;CAMBRIDGE, Mass.--(BUSINESS WIRE)--NinePoint Medical, Inc., an emerging leader in the development of medical devices for advanced optical imaging, today announced the commercial launch of its proprietary NvisionVLE...</description><pubDate>Thu, 16 May 2013 12:00:00 AM GMT</pubDate></item><item><title>New Welch Allyn Blood Pressure Averaging Technology Compensates for Misdiagnosis of Blood Pressure and White Coat Effect  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130513005098&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;MISSISSAUGA, Ontario--(BUSINESS WIRE)--Welch Allyn, a leading global provider of frontline medical products and solutions, recently introduced Office Profile, a new enhancement for the Welch Allyn Connex Vital...</description><pubDate>Mon, 13 May 2013 12:00:00 AM GMT</pubDate></item><item><title>AIBioTech Announces a New Test to Assess L-asparaginase Levels in Patients Undergoing Treatment for Acute Lymphoblastic Leukemia  </title><link>http://www.businesswire.com/portal/site/biospace2/template.PAGE/menuitem.ce58e8202d51f40bfcb16f10c0908a0c/index.jsp?ndmViewId=news_view&amp;newsId=20130204006305&amp;newsLang=en</link><description>RICHMOND, Va.--(BUSINESS WIRE)--AIBioTech is pleased to announce implementation of a new laboratory derived test to measure L-asparaginase levels in patients being treated with any of the current asparaginase drugs including: Oncaspar, Kidrolase, Erwinaze, and Elspar. About 5,500 new cases of pediatric acute lymphoblastic leukemia (ALL) are diagnosed in the United States each year. Unlike healthy...</description><pubDate>Tue, 05 Feb 2013 12:00:00 AM GMT</pubDate></item><item><title>Vitro Biopharma  Launches New Stem Cell Products to Accelerate Bone Growth  </title><link>http://www.globenewswire.com/news-release/2013/01/22/517729/10018796/en/Vitro-Biopharma-Launches-New-Stem-Cell-Products-to-Accelerate-Bone-Growth.html</link><description>GOLDEN, Colo., Jan. 22, 2013 (GLOBE NEWSWIRE) -- Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma, announced the launch of a series of products with application to accelerated bone growth, fracture healing and development of new osteoporosis drugs. The new products are osteoblasts derived from human adult stem cells known as mesenchymal stem cells (MSCs). These cells lead to bone growth and...</description><pubDate>Tue, 22 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Siemens Diagnostics???&lt;/b&gt; Sales Activities for NGAL Suspended Until Further  </title><link>http://www.globenewswire.com/news-release/2013/01/17/516918/0/en/Siemens-Diagnostics-sales-activities-for-NGAL-suspended-until-further.html</link><description>BioPorto has received notification from Siemens Diagnostics of a communication to their international subsidiaries putting a halt to sales activities concerning The NGAL TestTM. Siemens will refer interested customers to BioPorto. BioPorto is now looking further into the reasons for this and the prospects for activities being resumed.</description><pubDate>Thu, 17 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>Carestream Health, Inc. Shows New Tabletop Laser Imager for General Radiology, Mammography Imaging Applications  </title><link>http://www.biospace.com/news_story.aspx?StoryID=280001&amp;full=1</link><description>CHICAGO, Nov. 15  Carestream showed its new DRYVIEW 5950 Laser Imaging System that produces 508 pixels-per-inch output for general radiology and mammography images.   &lt;/p&gt;&lt;p&gt;The new imager can support efficient printing and time-saving film cartridges that can benefit healthcare providers of all sizes across the globe. The DRYVIEW 5950 laser imager also can deliver an enhanced quality control...</description><pubDate>Thu, 15 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Neurotrack&lt;/b&gt; Launches Early Diagnostic Test for Alzheimer's Disease  </title><link>http://www.biospace.com/news_story.aspx?StoryID=275082&amp;full=1</link><description>&lt;div id"releaseBody"&gt;&lt;p&gt;SANTA CLARA, CA--(Marketwire - October   03, 2012) -   Neurotrack, an early stage company, today launched at DEMO Fall 2012 a breakthrough technology that can diagnose Alzheimer's disease years before clinical symptoms appear. Based on results from a 5-year longitudinal study funded by the NIH, this computer-based recognition memory test has been able to predict Alzheimer...</description><pubDate>Thu, 04 Oct 2012 12:00:00 AM GMT</pubDate></item><item><title>Millennium Laboratories Launches New Assay to Detect Use of Kratom  </title><link>http://www.biospace.com/news_story.aspx?StoryID=271599&amp;full=1</link><description>SAN DIEGO&lt;/span&gt;, &lt;span class"xn-chron"&gt;Aug. 30, 2012&lt;/span&gt; /PRNewswire/ -- Millennium Laboratories, the leading research-based clinical diagnostic company dedicated to improving the lives of people suffering from pain and/or addiction, announced today the introduction of a new urine drug test designed to detect the presence of Kratom (Mitragyna speciosa). Kratom is a tropical tree native to &lt;span...</description><pubDate>Fri, 31 Aug 2012 12:00:00 AM GMT</pubDate></item><item><title>OxySure??? Systems, Inc. Launches Branded Line of Pulse Oximeters  </title><link>http://www.globenewswire.com/newsroom/news.html?d=10001373</link><description>FRISCO, Texas, Aug. 8, 2012 (GLOBE NEWSWIRE) -- OxySure Systems, Inc. (OTCBB:OXYS) ("OxySure"), the pioneering manufacturer of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced the launch of a branded line of pulse oximeters.</description><pubDate>Wed, 08 Aug 2012 12:00:00 AM GMT</pubDate></item><item><title>New Dome?? GX Series 4 Megapixel Widescreen Color Radiology Display Now Shipping From NDS Surgical Imaging  </title><link>http://www.businesswire.com/portal/site/biospace2/template.PAGE/menuitem.ce58e8202d51f40bfcb16f10c0908a0c/index.jsp?ndmViewId=news_view&amp;newsId=20120806005248&amp;newsLang=en</link><description>SAN JOSE, Calif.--(BUSINESS WIRE)--NDS Surgical Imaging (NDSsi) is now shipping its new Dome GX4MP radiology display, a 30-inch widescreen model offering multi-modality viewing in both color and grayscale. With resolution of 2500 x 1600, the GX4MP is ideal for reading Computed Tomography (CT) scans, MRI, PET-CT, Nuclear Medicine, Digital Pathology and Ultrasound. The product is also suited for Computed...</description><pubDate>Mon, 06 Aug 2012 12:00:00 AM GMT</pubDate></item><item><title>iCAD, Inc. Launches Next-Generation Mammography CAD Platform  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20120724006084&amp;newsLang=en</link><description>NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, announced today the availability of the PowerLook Advanced Mammography Platform (AMP), its next generation mammography computer-aided detection (CAD) system. PowerLook AMP provides radiologists...</description><pubDate>Tue, 24 Jul 2012 12:00:00 AM GMT</pubDate></item><item><title>FDA Grants CLIA Waiver to bioLytical??? Laboratories INSTI&amp;#0153; Rapid HIV Test  </title><link>http://www.globenewswire.com/newsroom/news.html?d=262974</link><description>VANCOUVER, British Columbia, July 23, 2012 (GLOBE NEWSWIRE) -- The INSTI Rapid HIV-1 Antibody Test, the world's only proven 60-second test for HIV/AIDS, is being made more widely available to the U.S. population. Found to meet the CLIA Waived performance requirements for finger-stick blood samples, INSTI can now be used by HIV testers and healthcare providers in a significantly expanded variety of...</description><pubDate>Mon, 23 Jul 2012 12:00:00 AM GMT</pubDate></item><item><title>IntelligentMDx Receives ISO Certification for Manufacturing Capabilities Compliant With the Canadian Medical Devices Conformity Assessment System  </title><link>http://www.biospace.com/news_story.aspx?StoryID=263028&amp;full=1</link><description>CAMBRIDGE, MA June 6, 2012 IMDx announces that they have received ISO certification to design, develop, and manufacture in vitro diagnostic devices for the diagnosis of infectious diseases in molecular biology, and will obtain licenses to commercialize the tests in Canada. &lt;/p&gt;&lt;p&gt;Under the Canadian Medical Devices Conformity Assessment System,  IMDx underwent a stringent audit of its quality...</description><pubDate>Wed, 06 Jun 2012 12:00:00 AM GMT</pubDate></item><item><title>Menssana Research, Inc. Develops Rapid Point-of-Care Breath Test for Pulmonary Tuberculosis  </title><link>http://www.biospace.com/news_story.aspx?StoryID=262181&amp;full=1</link><description>&lt;div id"releaseBody"&gt;&lt;p&gt;NEWARK, NJ--(Marketwire - May       30, 2012) -    A rapid point-of-care breath test accurately detected active pulmonary tuberculosis, according to a report published in the journal "Tuberculosis." Menssana Research developed the breath test in Newark, NJ and was funded by the National Institutes of Health and the US Air Force. &lt;p&gt;Researchers at four medical centers in...</description><pubDate>Thu, 31 May 2012 12:00:00 AM GMT</pubDate></item><item><title>BG Medicine Announces Availability of Galectin-3 Diagnostic Testing Through  </title><link>http://www.globenewswire.com/newsroom/news.html?d=255880</link><description>WALTHAM, Mass., May 14, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that Mayo Medical Laboratory (Mayo) now offers galectin-3 testing services to its laboratory customers and physicians. Mayo will offer the BGM Galectin-3TM test, which was cleared by the U.S. Food and Drug Administration...</description><pubDate>Mon, 14 May 2012 12:00:00 AM GMT</pubDate></item><item><title>Welch Allyn Introduces Industry???s First Extra Small Disposable Vaginal Speculum  </title><link>http://www.businesswire.com/portal/site/biospace2/index.jsp?ndmViewId=news_view&amp;newsId=20120507005022&amp;newsLang=en</link><description>SKANEATELES FALLS, N.Y.--(BUSINESS WIRE)--Welch Allyn, a leading global provider of medical diagnostic solutions, today introduced the industrys first extra small, disposable vaginal speculum at the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical Meeting in San Diego. Available for sale in August, the extra small KleenSpec Disposable Vaginal Speculum joins the company...</description><pubDate>Mon, 07 May 2012 12:00:00 AM GMT</pubDate></item><item><title>Bio-Reference Laboratories Announces IncellDx, Inc. Investment and Launch of GenCerv Test Through its GenPath Women???s Health Laboratory  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20120430005708&amp;newsLang=en</link><description>ELMWOOD PARK, N.J.--(BUSINESS WIRE)--Bio-Reference Laboratories, Inc. (BRLI) (NASDAQ: BRLI) announced today that it has completed an equity investment in InCellDx, Inc. (InCellDx), a privately held molecular diagnostics start-up company dedicated to the detection and monitoring of life -threatening diseases such as cervical cancer, breast cancer, HIV/AIDs, hepatitis and organ transplant rejection...</description><pubDate>Mon, 30 Apr 2012 12:00:00 AM GMT</pubDate></item><item><title>Vital Images, Inc. Introduces Universal Viewer to European Market at conhIT  </title><link>http://www.globenewswire.com/newsroom/news.html?d=252885</link><description>BERLIN, April 23, 2012 (GLOBE NEWSWIRE) -- Vital Images, Inc., a Toshiba Medical Systems Group Company and leading provider of advanced visualization and analysis solutions for healthcare providers, introduces VitreaView, a universal viewer that provides uniform access to patient imaging, at conhIT, Europe's leading event for healthcare IT 24-26 April in Berlin, Germany.</description><pubDate>Mon, 23 Apr 2012 12:00:00 AM GMT</pubDate></item><item><title>PositiveID (PSID)'s iglucose Mobile Health Solution Makes Significant Progress With Active Customer Deployments  </title><link>http://www.globenewswire.com/newsroom/news.html?d=252069</link><description>DELRAY BEACH, Fla., April 16, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), an emerging growth company and developer of advanced technologies for diabetes management as well as sophisticated airborne bio-threat detection systems for America's homeland defense, today announced significant progress with the initial deployment of its FDA-cleared iglucose mobile...</description><pubDate>Mon, 16 Apr 2012 12:00:00 AM GMT</pubDate></item><item><title>Syneron Medical Ltd. Announces International Launch of eLase(TM) Laser Hair Removal System  </title><link>http://www.biospace.com/news_story.aspx?StoryID=239978&amp;full=1</link><description>&lt;div id"releaseBody"&gt;&lt;p&gt;YOKNEAM, ISRAEL--(Marketwire - November  08, 2011) -    Syneron Medical Ltd. (NASDAQ: &lt;a href"http://www.marketwire.com/mw/stock.jsp?TickerELOS"&gt;ELOS&lt;/a&gt;), the leading global aesthetic device company, announced today the International launch of the eLase&amp;#8482; with Motif&amp;#8482; laser hair removal system. The eLase system will be unveiled at CosmoProf Asia 2011, November...</description><pubDate>Wed, 09 Nov 2011 12:00:00 AM GMT</pubDate></item><item><title>Corgenix Medical Corporation Partners with on SkyLAB 752??? Automated Testing Platform  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20111020006197&amp;newsLang=en</link><description>DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTCQB: CONX), a worldwide developer and marketer of diagnostic test kits, has entered into a U.S. distribution agreement with strategic partner AXA Diagnostics Srl of Pomezia, Italy. Under terms of the agreement, Corgenix will market AXA Diagnostics proprietary SkyLAB 752 ELISA/IFA Analyzer on a non-exclusive basis in the United States. </description><pubDate>Thu, 20 Oct 2011 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Celsis Rapid Detection&lt;/b&gt; ReACT??? Now Includes a Staph Aureus Kit   </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20111017005088&amp;newsLang=en</link><description>CHICAGO--(BUSINESS WIRE)--Celsis Rapid Detection, the global leader in rapid microbial detection solutions for industry, announces the addition of a Staphylococcus aureus kit to the Celsis ReACT family of rRNA-based microbial assays used for the rapid detection of objectionable organisms. </description><pubDate>Mon, 17 Oct 2011 12:00:00 AM GMT</pubDate></item><item><title>OrSense Ltd.'s Non-Invasive Hemoglobin Monitor Offers for the First Time the Ability to Detect Hemorrhage Accurately and Within Minutes  </title><link>http://www.businesswire.com/portal/site/biospace2/index.jsp?ndmViewId=news_view&amp;newsId=20111017005646&amp;newsLang=en</link><description>NES ZIONA, Israel--(BUSINESS WIRE)--OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, presented in an oral presentation at the American Society of Anesthesiologists (ASA) annual meeting in Chicago, results showing that its NBM 200MP, a non-invasive Hemoglobin (Hb) measurement system, detects hemorrhage accurately and within minutes. The sensitivity of the...</description><pubDate>Mon, 17 Oct 2011 12:00:00 AM GMT</pubDate></item><item><title>SurModics Inc. IVD Introduces A New BioFX?? TMB Enhanced HRP Membrane Substrate  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20110920005226&amp;newsLang=en</link><description>EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics IVD introduces BioFX TMB Enhanced HRP Membrane Substrate. SurModics IVD, a wholly owned subsidiary of SurModics, Inc. (Nasdaq: SRDX), is a market leader for immunoassay reagents for diagnostic test kits used to detect absence or presence of disease. </description><pubDate>Tue, 20 Sep 2011 12:00:00 AM GMT</pubDate></item><item><title>Phadia AB Announces First-Ever Commercial Availability of Peanut Allergen Component Tests  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20110816005875&amp;newsLang=en</link><description>PORTAGE, Mich.--(BUSINESS WIRE)--Today Phadia, the global leader in allergy and autoimmune disease-related diagnostics, announced that the uKnow Peanut Test, its peanut allergen component test, is now commercially available in the United States through the Phadia Immunology Reference Laboratory (PiRL). FDA clearance of the individual peanut component tests, announced in May 2011, brings these cutting...</description><pubDate>Tue, 16 Aug 2011 12:00:00 AM GMT</pubDate></item><item><title>SDIX Announces Expansion of IVD Reagents Portfolio  </title><link>http://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&amp;newsId=20110802006706&amp;newsLang=en</link><description>NEWARK, Del.--(BUSINESS WIRE)--SDIX (NASDAQ: SDIX), a leading provider of In Vitro Diagnostic (IVD) reagents, announced the addition of nine new polyclonal antibodies to its product line for the IVD market while exhibiting at AACC last week. These products include Apo A1, Lp(a), HPT, CER, IgM, IgG(Fc), IgA, C3 and C4. The antibodies can be customized for in vitro diagnostics and will be available as...</description><pubDate>Wed, 03 Aug 2011 12:00:00 AM GMT</pubDate></item><item><title>SurModics Inc. Introduces New In Vitro Diagnostics Product ??? SurModics(R) Assay Diluent (Protein-Free)  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20110726005746&amp;newsLang=en</link><description>EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, will introduce its SurModics Assay Diluent (Protein-Free) product at the American Association for Clinical Chemistry (AACC)  Clinical Lab Expo, July 26-28, 2011 in Atlanta, GA (booth #1302).</description><pubDate>Tue, 26 Jul 2011 12:00:00 AM GMT</pubDate></item><item><title>Illumina, Inc. Announces First Customer Shipments of the Omni5 BeadChip  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20110725005568&amp;newsLang=en</link><description>SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) today announced that it has begun shipping the HumanOmni5-Quad DNA Analysis BeadChip (Omni5), the new flagship array of the Omni family of microarrays.</description><pubDate>Mon, 25 Jul 2011 12:00:00 AM GMT</pubDate></item><item><title>SDIX Launches Apo B Antibody in IVD Market  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20110720006936&amp;newsLang=en</link><description>NEWARK, Del.--(BUSINESS WIRE)--SDIX (NASDAQ: SDIX), a leading provider of In Vitro Diagnostic (IVD) reagents, today announced its plan to introduce a new polyclonal antisera to its product line for the IVD market. The product, Apo B, will be available as antisera and in fractionated forms.</description><pubDate>Thu, 21 Jul 2011 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Astra Biotech GmbH&lt;/b&gt; Release: New Microarray-On-A-Chip Test for Cystic Fibrosis  </title><link>http://www.biospace.com/news_story.aspx?StoryID=226697&amp;full=1</link><description>July 2011 -- Astra Biotech GmbH is in the pre-launch phase of its newly developed test, based on microarray technology, for rapid simultaneous detection of 25 of the most common mutations causing cystic fibrosis in pan-European populations. This initiative supports Astra Biotechs aim of facilitating early diagnosis of individuals risk factors through innovative assays. In this way long-term effects...</description><pubDate>Tue, 12 Jul 2011 12:00:00 AM GMT</pubDate></item><item><title>OpGen, Inc. Release: Optical Mapping First to Definitively Determine Deadly E. coli Strains in German Outbreak Are From a Single Source and Related to Earlier Outbreaks  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20110613006109&amp;newsLang=en</link><description>GAITHERSBURG, Md.--(BUSINESS WIRE)--OpGen, Inc. today announced successful completion of whole genome maps of the German outbreak E. coli isolates, performed in cooperation with the University Hospital Mnster, Germany on the Argus Optical Mapping System. In less than 48 hours, the company completed de novo, whole genome maps of six isolates from the outbreak and reference strains, confirming that...</description><pubDate>Mon, 13 Jun 2011 12:00:00 AM GMT</pubDate></item><item><title>CDEX Inc. ID2 Product Line Gains CE Certifications, Begins Distribution in European Union Countries  </title><link>http://www.biospace.com/news_story.aspx?StoryID=223390&amp;full=1</link><description>&lt;div id"releaseBody"&gt;&lt;p&gt;TUCSON, AZ--(Marketwire - June      08, 2011) -  &lt;table class"releaseLink"&gt;&lt;tr&gt;&lt;td class"releaseLink"&gt;&lt;b&gt;Highlighted Links&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;a href"http://www2.marketwire.com/mw/mmframe?prid765574&amp;attachid1637909"&gt;http://www.cdexinc.com&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;a href"http://www2.marketwire.com/mw/mmframe?prid765574&amp;attachid1637908"&gt;http...</description><pubDate>Wed, 08 Jun 2011 12:00:00 AM GMT</pubDate></item><item><title>NanoLogix, Inc. Announces European Clinical Trial of Its Rapid Detection Kits   </title><link>http://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&amp;newsId=20110607005595&amp;newsLang=en</link><description>HUBBARD, Ohio--(BUSINESS WIRE)--NanoLogix (PINK SHEETS: NNLX), a biotechnology innovator in the rapid detection and identification of live-cell bacteria and microorganisms, announced today its BioNanoFilter (BNF) technology will undergo a clinical trial, led by Dr. Gian Carlo Di Renzo of the University of Perugia in Italy. The 300 patient trial will study the speed and accuracy of NanoLogix technology...</description><pubDate>Tue, 07 Jun 2011 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;MDxHealth&lt;/b&gt;'s Methylation Based Companion Diagnostics Enables Better Personalized Treatment in Brain Cancer   </title><link>http://www.biospace.com/news_story.aspx?StoryID=222405&amp;full=1</link><description>DURHAM, NC, and LIEGE, BELGIUM - May 31, 2011 - MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostics company in the field of personalized cancer treatment, today announced that its MGMT test (PredictMDXTM for Brain) has demonstrated success in personalizing brain cancer treatment in a major international phase III study. The data, obtained from a Phase III study (RTOG 0525) of temozolomide...</description><pubDate>Tue, 31 May 2011 12:00:00 AM GMT</pubDate></item><item><title>New CE Marked Prognostic Claim for Accumetrics, Inc.'s VerifyNow P2Y12 Test  </title><link>http://www.biospace.com/news_story.aspx?StoryID=221002&amp;full=1</link><description>&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;SAN DIEGO&lt;/span&gt;, &lt;span class"xn-chron"&gt;May 17, 2011&lt;/span&gt; /PRNewswire/ -- Accumetrics, Inc., developer of the VerifyNow System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the VerifyNow P2Y12 Test is now CE marked for prognostic use in identifying...</description><pubDate>Tue, 17 May 2011 12:00:00 AM GMT</pubDate></item><item><title>Intermountain Healthcare Establishes Reimbursement Coverage Policy for Pathway Diagnostics??? Tissue of Origin Test  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20110517005272&amp;newsLang=en</link><description>REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pathwork Diagnostics, Inc., a privately held molecular diagnostics company focused on oncology, announced today that its Pathwork Tissue of Origin Test is now covered by SelectHealth, the health insurance arm of Intermountain Healthcare. The Tissue of Origin Test helps identify the primary tumor in difficult to diagnose cancer cases, such as those that are metastatic...</description><pubDate>Tue, 17 May 2011 12:00:00 AM GMT</pubDate></item><item><title>Roche Diagnostics Corporation Launches the Cobas(R) 8000 Modular Analyzer Series in Canada at  </title><link>http://www.biospace.com/news_story.aspx?StoryID=220494&amp;full=1</link><description>&lt;div class"xn-content"&gt;&lt;p&gt;&lt;i&gt;&lt;b&gt;&lt;span class"xn-location"&gt;Vancouver&lt;/span&gt; site represents first North American installation of new high volume analyz&lt;/b&gt;&lt;/i&gt;&lt;i&gt;&lt;b&gt;er.&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;&lt;p align"left"&gt;&lt;span class"xn-location"&gt;LAVAL, QC&lt;/span&gt;, &lt;span class"xn-chron"&gt;May 12&lt;/span&gt; /PRNewswire/ - Roche Diagnostics Canada is pleased to announce the launch of the cobas 8000 modular analyzer series. In...</description><pubDate>Thu, 12 May 2011 12:00:00 AM GMT</pubDate></item><item><title>Biomagnetics Diagnostics Corporation Unveils World???s First Urine-Based Tuberculosis Diagnostics Tool in New Video  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20110509005907&amp;newsLang=en</link><description>Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP - News) a developer of revolutionary diagnostics systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, in a new video today unveiled the worlds first urine-based tuberculosis diagnostics tool. This revolutionary optical biosensor diagnostics device was developed by top scientists...</description><pubDate>Mon, 09 May 2011 12:00:00 AM GMT</pubDate></item><item><title>New EndoChoice Products Revolutionize GI Practices  </title><link>http://www.biospace.com/news_story.aspx?StoryID=219904&amp;full=1</link><description>&lt;div id"releaseBody"&gt;&lt;div class"releaseMediaMW"&gt;&lt;img src"http://media.marketwire.com/attachments/201105/TN-64364_giDash.jpg" alt"giDash from EndoChoice offers busy GI physicians at-a-glance access to key financial and clinical performance metrics."&gt;&lt;br&gt;&lt;a href"http://www2.marketwire.com/mw/frame_multimedia?prid753462&amp;attachid1603687"&gt;(Click here for details)&lt;br&gt; giDash from EndoChoice offers...</description><pubDate>Mon, 09 May 2011 12:00:00 AM GMT</pubDate></item><item><title>Quest Diagnostics Inc. Launches Simplexa(TM) C. Difficile Universal Direct Test in Europe  </title><link>http://www.biospace.com/news_story.aspx?StoryID=219491&amp;full=1</link><description>&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;MADISON, N.J.&lt;/span&gt; and &lt;span class"xn-location"&gt;CYPRESS, Calif.&lt;/span&gt;, &lt;span class"xn-chron"&gt;May 5, 2011&lt;/span&gt; /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced the availability in &lt;span class"xn-location"&gt;Europe&lt;/span&gt; of the Simplexa ...</description><pubDate>Thu, 05 May 2011 12:00:00 AM GMT</pubDate></item><item><title>Source MDx Announces 16 Molecular Diagnostic Development Programs Will Be Offered for Sale on April 29, 2011  </title><link>http://www.biospace.com/news_story.aspx?StoryID=215383&amp;full=1</link><description>&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;WELLESLEY HILLS, Mass.&lt;/span&gt;, &lt;span class"xn-chron"&gt;March 29, 2011&lt;/span&gt;  /PRNewswire/ -- &lt;span class"xn-person"&gt;Joseph F. Finn, Jr.&lt;/span&gt;, C.P.A. ("Finn") Assignee for the Benefit of Creditors of Source Precision Medicine, Inc., d/b/a Source MDx  ("Source MDx") announced that 16 molecular diagnostic development programs will be offered for...</description><pubDate>Tue, 29 Mar 2011 12:00:00 AM GMT</pubDate></item><item><title>Stroke Detection Breakthrough: Jan Medical, Inc.'s Portable Brain Imaging System Can Rapidly Detect Many Abnormal Neurological Conditions that Have a Vascular Basis  </title><link>http://www.biospace.com/news_story.aspx?StoryID=215234&amp;full=1</link><description>MOUNTAIN VIEW, Calif., March 28, 2011  Jan Medical (www.janmedical.com) announced today that clinical data related to its portable brain imaging system will be disclosed from the podium at a major scientific meeting this week that will demonstrate a breakthrough in detecting strokes.&lt;/p&gt;&lt;p&gt;The data will be presented at the podium during the annual scientific meeting of the Society of Interventional...</description><pubDate>Mon, 28 Mar 2011 12:00:00 AM GMT</pubDate></item><item><title>PositiveID (PSID) Completes Development of Its iglucose(TM) Mobile Health Solution for Real-Time Diabetes Management  </title><link>http://www.globenewswire.com/newsroom/news.html?d=215767</link><description>DELRAY BEACH, Fla., March 9, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or the "Company") (Nasdaq:PSID) announced today that it has completed the development of its iglucose wireless communication system for real-time diabetes management. iglucose is a wireless device that connects to any data-capable glucometer to automatically communicate blood glucose readings to a secure online...</description><pubDate>Wed, 09 Mar 2011 12:00:00 AM GMT</pubDate></item><item><title>Pharmaxis Ltd Launches ARIDOL(R) (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness  </title><link>http://www.biospace.com/news_story.aspx?StoryID=211785&amp;full=1</link><description>&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;EXTON, Pa.&lt;/span&gt;, &lt;span class"xn-chron"&gt;Feb. 23, 2011&lt;/span&gt; /PRNewswire/ -- Pharmaxis, a global specialty pharmaceutical company focused on therapeutic products for chronic respiratory and immune disorders, announced today the commercial launch of ARIDOL (mannitol inhalation powder)&lt;b&gt;&lt;/b&gt;Bronchial Challenge Test Kit, the first new bronchial...</description><pubDate>Thu, 24 Feb 2011 12:00:00 AM GMT</pubDate></item><item><title>HVAC Technicians Get Advantages They Need With New Fluke Corporation Test Tools  </title><link>http://www.biospace.com/news_story.aspx?StoryID=209198&amp;full=1</link><description>&lt;div id"releaseBody"&gt;&lt;p&gt;EVERETT, WA--(Marketwire - January   31, 2011) -  &lt;table class"releaseLink"&gt;&lt;tr&gt;&lt;td class"releaseLink"&gt;&lt;b&gt;Highlighted Links&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;a href"http://www2.marketwire.com/mw/mmframe?prid714514&amp;attachid1495987"&gt;Fluke Corporation &lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;  2011 AHR Expo Booth #C838 -- As technicians describe their expectations for 2011, Fluke Corporation...</description><pubDate>Tue, 01 Feb 2011 12:00:00 AM GMT</pubDate></item><item><title>Miraculins Inc. Announces Plans to Launch PREVU in Q4 2011  </title><link>http://www.biospace.com/news_story.aspx?StoryID=207390&amp;full=1</link><description>&lt;div id"releaseBody"&gt;&lt;p&gt;WINNIPEG, MANITOBA--(Marketwire - January   11, 2011) -    Miraculins Inc. (TSX VENTURE: &lt;a href"http://www.marketwire.com/mw/stock.jsp?TickerTSXV:MOM"&gt;MOM&lt;/a&gt;), a medical diagnostic company focused on developing and commercializing risk assessment and diagnostic tests for unmet clinical needs, has announced plans to make its PREVU(i) technology available for commercial sale...</description><pubDate>Tue, 11 Jan 2011 12:00:00 AM GMT</pubDate></item><item><title>InfraReDx Announces Publication of a Case Report in Circulation Highlighting Novel Clinical Finding with LipiScan(TM) Coronary Imaging System  </title><link>http://www.biospace.com/news_story.aspx?StoryID=204645&amp;full=1</link><description>BURLINGTON, Mass. (December 7, 2010)  InfraReDx, Inc., a medical device company developing intelligent cardiovascular diagnostic imaging technologies, today announced the publication of a case report in Circulation describing the association of stent thrombosis with lipid core plaque as detected by its LipiScan Coronary Imaging System. The LipiScan is the first and only FDA-approved system to provide...</description><pubDate>Tue, 07 Dec 2010 12:00:00 AM GMT</pubDate></item><item><title>Syprosoft, Inc. Engineering Develops First Prototype G1A(TM) Reader for Epinex Diagnostics  </title><link>http://www.businesswire.com/news/biospace/20101020006857/en/Syprosoft-Engineering-Develops-Prototype-G1A%E2%84%A2-Reader-Epinex</link><description>IRVINE, Calif.--(BUSINESS WIRE)--Syprosoft Engineering has announced that they successfully completed development of a prototype for The G1A Rapid Diabetes Monitoring Index Reader, a revolutionary diabetes monitoring test. The prototype, developed for Epinex Diagnostics, was completed in 2009 and exemplifies the type of work in which Syprosoft Engineering takes pride.</description><pubDate>Thu, 21 Oct 2010 12:00:00 AM GMT</pubDate></item><item><title>Atherotech, Inc. Lab to Showcase Value of VAP(R) Cholesterol Test in Diagnosis, Treatment Management  </title><link>http://www.businesswire.com/news/biospace/20101021005202/en/Atherotech-Diagnostics-Lab-Showcase-VAP%C2%AE-Cholesterol-Test</link><description>BIRMINGHAM, Ala.--(BUSINESS WIRE)--Atherotech Diagnostics Lab will showcase its VAP Cholesterol Test in booth 324 at the American Osteopathic Associations 115th Annual Osteopathic Medical Conference &amp; Exposition (OMED 2010). The gathering of DOs, residents, interns, students, researchers and health care professionals will be held October 24-28 at Moscone Convention Center in San Francisco.</description><pubDate>Thu, 21 Oct 2010 12:00:00 AM GMT</pubDate></item><item><title>Radient Pharmaceuticals and Provista Life Sciences LLC Announce New Blood Test for Lung Cancer  </title><link>http://www.biospace.com/news_story.aspx?StoryID=197802&amp;full=1</link><description>&lt;div id"releaseBody"&gt;&lt;p&gt;TUSTIN, CA--(Marketwire - October   13, 2010) -   Provista Life Sciences and Radient Pharmaceuticals Corporation (RPC) (NYSE Amex: &lt;a href"http://www.marketwire.com/mw/stock.jsp?TickerRPC"&gt;RPC&lt;/a&gt;) announced today the validation study results of a blood test for early detection of lung cancer and Provista's plans to broadly introduce this new test to market.&lt;p&gt;The study...</description><pubDate>Wed, 13 Oct 2010 12:00:00 AM GMT</pubDate></item><item><title>Nanosphere, Inc.'s Verisens(TM) Ultra-Sensitive PSA Assay Combined With the AnalizaDx SIA Technology Shows Promising Results for Improved Prostate Cancer Diagnosis  </title><link>http://www.globenewswire.com/newsroom/news.html?d=203177</link><description>NORTHBROOK, Ill. and CLEVELAND, Oct. 7, 2010 (GLOBE NEWSWIRE) -- At the annual meeting of the North-Central American Urological Association, Mark Stovsky, MD, Case Western Reserve University School of Medicine  Case Medical Center, and principal investigator, presented positive data combining the AnalizaDx SIA technology with the Nanosphere Verisens ultra-sensitive PSA assay (research use only)...</description><pubDate>Thu, 07 Oct 2010 12:00:00 AM GMT</pubDate></item><item><title>IncellDx, Inc. Announces Successful Presentation of Its Personalized HIV Monitoring Assays at the 5th Conference in Greece  </title><link>http://www.businesswire.com/news/biospace/20101006005585/en/IncellDx-Announces-Successful-Presentation-Personalized-HIV-Monitoring</link><description>MENLO PARK, Calif.--(BUSINESS WIRE)--IncellDx, Inc. announces the presentation of multicenter data by Dr. George Lallas of FlowCytoGen Laboratories at the '5th Santorini Conference on Functional Genomics towards a Personalized Health Care.' Dr. Lallas talk described how the combination of the HIV Reservoirs Assay and the HIV Tropism Assay are effective in the determination of efficacy for HIV therapy...</description><pubDate>Wed, 06 Oct 2010 12:00:00 AM GMT</pubDate></item><item><title>New Test in the Treatment of Lung Cancer, Rosetta Genomics Ltd. Reveals  </title><link>http://www.survivingmesothelioma.com/news/view.asp?ID=001005</link><description>(Ivanhoe Newswire)  There are 169,399 people diagnosed with lung cancer each year. About 1 in 45 women and 1 in 22 men will develop it during their lifetime.  A new test could allow for a more precise diagnosis and better targeted therapy for patients with lung cancer.</description><pubDate>Mon, 04 Oct 2010 12:00:00 AM GMT</pubDate></item><item><title>QIAGEN N.V. Launches CE- IVD Marked Tests for Companion Diagnostics  </title><link>http://www.biospace.com/news_story.aspx?StoryID=196661&amp;full=1</link><description>Hilden, Germany  October 04, 2010  QIAGEN today announced the launch of several tests for cancer companion diagnostics, CE-marked with the Rotor-Gene Q thermocycler (EGFR) and the PyroMark pyrosequencing system (EGFR, NRAS, KRAS, BRAF). The new tests are used in personalized healthcare of cancer by identifying certain mutations in these particular genes, which then help clinicians to select and...</description><pubDate>Mon, 04 Oct 2010 12:00:00 AM GMT</pubDate></item><item><title>BioCurex Inc. Announces Commercial Launch of Its RECAF Blood Test to Detect Cancer in Dogs  </title><link>http://globenewswire.com/newsroom/news.html?d=202663</link><description>RICHMOND, British Columbia, Sept. 30, 2010 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) announced the commercial launch of its RECAF blood test for cancer in dogs through its wholly owned subsidiary, OncoPet Diagnostics.</description><pubDate>Thu, 30 Sep 2010 12:00:00 AM GMT</pubDate></item><item><title>OrSense Ltd. Introduces Non-Invasive Hemoglobin System for Anemia Monitoring in Maternal Health  </title><link>http://www.businesswire.com/news/biospace2/20100927005695/en/OrSense-Introduces-Non-Invasive-Hemoglobin-System-Anemia-Monitoring</link><description>NES ZIONA, Israel--(BUSINESS WIRE)--OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, introduced at the Global Forum of Maternal and Infant Health, at Barcelona, Spain, NBM200, a non-invasive hemoglobin (Hb) measurement system for anemia screening and hemorrhage detection. The Company presented results showing that Hb measurements obtained by the NBM20...</description><pubDate>Mon, 27 Sep 2010 12:00:00 AM GMT</pubDate></item><item><title>Chronix Biomedical Release: New Concerns About Mad Cow Disease Highlight Importance of Chronix Blood Test That Can Detect BSE Before Symptoms Appear  </title><link /><description>Sioux Falls, SD and San Jose, CA, September 27, 2010  Chronix Biomedical today announced that its CEO, Dr. Howard Urnovitz, will discuss the companys unique DNA biomarker technology for the detection of bovine spongiform encephalopathy (BSE), or mad cow disease, on a panel at the South Dakota Biotech Associations Livestock Network conference.  &lt;/p&gt;&lt;p&gt;Chronix has developed a serum test for the...</description><pubDate>Mon, 27 Sep 2010 12:00:00 AM GMT</pubDate></item><item><title>New Computer-Tomography Method Visualizes Nano-Structure Of Bones, Technische Universitat Munchen Reveals  </title><link>http://www.sciencedaily.com/releases/2010/09/100922132000.htm</link><description>Medical News Today -- A novel nano-tomography method developed by a team of researchers from the Technische Universitaet Muenchen, the Paul Scherrer Institute and the ETH-Zurich opens the door to computed tomography examinations of minute structures at nanometer resolutions. Three-dimensional detailed imaging of fragile bone structures becomes possible. Their first nano-CT images will be published...</description><pubDate>Fri, 24 Sep 2010 12:00:00 AM GMT</pubDate></item><item><title>St. Jude Medical to Showcase New Lesion Assessment Technology at 2010  </title><link>http://www.businesswire.com/news/biospace/20100922005382/en/St.-Jude-Medical-Showcase-Lesion-Assessment-Technology</link><description>ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, will highlight recently launched technology, including its new Optical Coherence Tomography (OCT) product platform, at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington, D.C. The new C7-XR OCT Intravascular Imaging System complements the companys PressureWire...</description><pubDate>Wed, 22 Sep 2010 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;ALLPRO Imaging&lt;/b&gt; Introduces ScanX Quantum(TM) Digital Imaging Body and Dental Digital Images in One Compact System  </title><link>http://www.businesswire.com/news/biospace2/20100908005619/en/ALLPRO-Imaging-Introduces-ScanX-Quantum%E2%84%A2-Digital-Imaging</link><description>MELVILLE, N.Y.--(BUSINESS WIRE)--ALLPRO Imaging, a leader in digital imaging systems, introduces the ScanX Quantum, the most compact and versatile system for community health centers interested in upgrading to digital. It is the only system capable of body images up to 14 wide by any practical length and dental images in sizes 0-4. Made in the U.S.A., the ScanX Quantum is compact and lightweight ...</description><pubDate>Wed, 08 Sep 2010 12:00:00 AM GMT</pubDate></item><item><title>Cancer Detection? There's an App for That, Harvard University and Collaborators Reveal  </title><link>http://www.dotmed.com/news/story/14131/</link><description>DOTmed News -- Cell phones could help doctors detect deadly cancers, thanks to a joint effort between the Mazumdar Shaw Cancer Center (MSCC) of the Narayana Hrudayalaya Hospital in India and Sana, a research group at Harvard/MIT.</description><pubDate>Tue, 07 Sep 2010 12:00:00 AM GMT</pubDate></item><item><title>UVP, LLC Release: iBox(R) Explorer(TM) Fluorescence Imaging Microscope Released at the 2010 Conference in Kyoto Japan  </title><link>http://www.biospace.com/news_story.aspx?StoryID=193070&amp;full=1</link><description>September, 2010 -- UVP, LLC will exhibit at World Molecular Imaging Conference in Kyoto, Japan from September 8  11, 2010 to showcase the new iBox Explorer Fluorescence Imaging Microscope along with UVPs extensive line of iBox in vivo imaging systems for rapid high resolution analysis of fluorescently tagged cells, tissues, organs and whole animals in the visible and NIR wavelengths. UVP now offers...</description><pubDate>Fri, 03 Sep 2010 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Tanaka Precious Metals&lt;/b&gt; Succeeds in Development of High-sensitivity In-vitro Diagnostic Kit; Expected to Contribute to Early Discovery of Prostate Cancer  </title><link>http://www.japancorp.net/portal/biospace/index.asp?id=23059</link><description>Tokyo, Sept 3, 2010 (JCN Newswire) - Tanaka Holdings Co., Ltd. (Holding company of Tanaka Precious Metals, Head office: Marunouchi, Chiyoda-ku, Tokyo; President &amp; CEO: Hideya Okamoto) today announced that Tanaka Kikinzoku Kogyo K.K. (Head office: Marunouchi, Chiyoda-ku, Tokyo; President &amp; CEO: Hideya Okamoto), which operates the Tanaka Precious Metals's manufacturing business, succeeded in the development...</description><pubDate>Fri, 03 Sep 2010 12:00:00 AM GMT</pubDate></item><item><title>Cepheid's 'Revolutionary' Test Identifies TB Within Two Hours  </title><link>http://www.reuters.com/article/idUSTRE68071A20100901?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FhealthNews+%28News+%2F+US+%2F+Health+News%29</link><description>AP -- Scientists are reporting a major advance in diagnosing tuberculosis: A new test can reveal in less than two hours, with very high accuracy, whether someone has the disease and if it's resistant to the main drug for treating it.</description><pubDate>Thu, 02 Sep 2010 12:00:00 AM GMT</pubDate></item><item><title>Canon Inc. Enhances Digital Radiography Lineup with the New, CXDI-70C Wireless Digital Radiography Detector at Expo  </title><link>http://www.businesswire.com/news/biospace2/20100901005048/en/Canon-Enhances-Digital-Radiography-Lineup-CXDI-70C-Wireless</link><description>NEW YORK--(BUSINESS WIRE)--Canon Expo 2010 in New York City ushers in a new era of mobility and flexibility, including the addition of the Companys first wireless detector, the CXDI-70C Wireless Digital Radiography System1. Featuring a versatile 14-inch by 17-inch image area, same dimensions ISO 4090 film cassette and cable-free image transfer, the new wireless detector weighs 7.5 pounds-the lightest...</description><pubDate>Wed, 01 Sep 2010 12:00:00 AM GMT</pubDate></item><item><title>QIAGEN N.V. Introduces QIAsymphony RGQ(R), a Novel Automated System for all Molecular Testing Needs  </title><link>http://www.biospace.com/news_story.aspx?StoryID=192827&amp;full=1</link><description>VENLO, The Netherlands  September 01, 2010  QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its highly flexible automated solution QIAsymphony RGQ. This novel, integrated system sets new standards for molecular testing and incorporates all workflow steps from sample to detection. QIAsymphony offers many features which create exceptional flexibility, such as...</description><pubDate>Wed, 01 Sep 2010 12:00:00 AM GMT</pubDate></item><item><title>Laboratory Corporation of America Holdings (LabCorp) Enhances HCV Testing Services with the Launch of IL-28B Test  </title><link>http://www.businesswire.com/news/biospace/20100823006144/en/LabCorp-Enhances-HCV-Testing-Services-Launch-IL-28B</link><description>BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America Holdings (LabCorp) (NYSE: LH) announced today the nationwide availability of a genetic test to detect the presence of a single polymorphism within the IL-28B gene that has been reported to help predict a persons response to certain hepatitis C virus (HCV) therapies.</description><pubDate>Tue, 24 Aug 2010 12:00:00 AM GMT</pubDate></item><item><title>CaridianBCT, Inc. Launches Latest Version of Trima Accel(R) Automated Blood Collection System  </title><link>http://www.businesswire.com/news/biospace2/20100817005611/en/CaridianBCT-Launches-Latest-Version-Trima-Accel%C2%AE-Automated</link><description>LAKEWOOD, Colo.--(BUSINESS WIRE)--CaridianBCT, the leading global provider of technology, products and services in the blood banking, transfusion medicine and cell therapy industries, announced the global release of the Trima Accel Automated Blood Collection System Version 6.0. The latest version of the flagship automated blood collection platform provides streamlined operations and potentially increased...</description><pubDate>Tue, 17 Aug 2010 12:00:00 AM GMT</pubDate></item><item><title>A New Talking Meter for Blood Glucose, BioSense Medical Devices Reveals  </title><link>http://www.biospace.com/news_story.aspx?StoryID=190903&amp;full=1</link><description>At least 38 companies now offer us meters that we can use to test our blood. I list and link them in my web page Blood Glucose Meters, Part 14 of the On-line Diabetes Resources. &lt;/p&gt;&lt;p&gt;Almost all of those 38 companies sell their meters in the U.S., and most of them have several different meters for sale here. So why would we ever need a new one?&lt;/p&gt;&lt;p&gt;For one thing, meters are getting better...</description><pubDate>Thu, 12 Aug 2010 12:00:00 AM GMT</pubDate></item><item><title>AdvanDx, Inc. Launches GNR Traffic Light(TM) PNA FISH(R) in Europe  </title><link>http://www.biospace.com/news_story.aspx?StoryID=190914&amp;full=1</link><description>Woburn, MA, U.S.A. and Vedbaek, Denmark  August 12, 2010  AdvanDx today announced the launch of its CE-IVD marked GNR Traffic Light PNA FISH test in Europe.  GNR Traffic Light PNA FISH is the first-ever test capable of simultaneously identifying Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa directly from positive blood cultures in less than 90 minutes.  The GNR Traffic Light...</description><pubDate>Thu, 12 Aug 2010 12:00:00 AM GMT</pubDate></item><item><title>British Scientists Develop Brain Scan to Detect Autism, Institute of Psychiatry, King's College London Study  </title><link>http://www.bbc.co.uk/news/health-10929032</link><description>Yahoo! News -- LONDON (AFP)  British scientists have developed a 15-minute brain scan they hope could be used to detect autism in children, cutting both the time and cost of diagnosing the disorder.</description><pubDate>Wed, 11 Aug 2010 12:00:00 AM GMT</pubDate></item><item><title>Glycated Hemoglobin As A Diagnostic Test For Diabetes Predicts Mortality More Accurately Than Fasting Glucose  </title><link>http://scienceblips.dailyradar.com/story/glycated-hemoglobin-as-a-diagnostic-test-for-diabetes/</link><description>Blogspot -- Fasting glucose is the standard measure used to diagnose diabetes in the United States. Recently, glycated hemoglobin was also recommended for this purpose.</description><pubDate>Wed, 11 Aug 2010 12:00:00 AM GMT</pubDate></item><item><title>New Device For Patients to Monitor Blood Glucose Levels, Massachusetts Institute of Technology (MIT) Reveals  </title><link>http://www.physorg.com/news200590475.html</link><description>Physorg.com -- People with type 1 diabetes must keep a careful eye on their blood glucose levels: Too much sugar can damage organs, while too little deprives the body of necessary fuel. Most patients must prick their fingers several times a day to draw blood for testing.</description><pubDate>Tue, 10 Aug 2010 12:00:00 AM GMT</pubDate></item><item><title>Spartan Bioscience Announces First Point-of-Care DNA Testing System for Personalized Medicine  </title><link>http://www.businesswire.com/news/biospace/20100810005233/en/Spartan-Bioscience-Announces-Point-of-Care-DNA-Testing-System</link><description>OTTAWA, Ontario--(BUSINESS WIRE)--Spartan Bioscience Inc., a privately held molecular diagnostics company that develops, manufactures, and markets DNA testing systems for on-demand applications, today announced the availability of the Spartan RX, the first complete sample-to-result, point-of-care DNA testing system for personalized medicine. The non-invasive and easy-to-use system provides automated...</description><pubDate>Tue, 10 Aug 2010 12:00:00 AM GMT</pubDate></item><item><title>Promega Corporation Improves Sensitivity for RNA Quantification with New GoTaq(R) 2-Step RT-qPCR System  </title><link>http://www.businesswire.com/news/biospace/20100810005202/en/Promega-Improves-Sensitivity-RNA-Quantification-GoTaq%C2%AE-2-Step</link><description>MADISON, Wis.--(BUSINESS WIRE)--The new Promega GoTaq 2-Step RT-qPCR System allows researchers to detect target genes expressed at low levels even with hard-to-amplify samples. Enhanced sensitivity of the two-step system extends the broad dynamic range of RNA quantitation and provides a robust, gene expression analysis tool.</description><pubDate>Tue, 10 Aug 2010 12:00:00 AM GMT</pubDate></item><item><title>New Diagnostic Chip Able To Generate Single-Cell Molecular 'Fingerprints' For Brain Tumors, University of California, Los Angeles (UCLA) Study  </title><link>http://www.sciencedaily.com/releases/2010/08/100803101926.htm</link><description>ScienceDaily (Aug. 2, 2010)  New technologies for the diagnosis of cancer are rapidly changing the clinical practice of oncology. As scientists learn more about the molecular basis of cancer, the development of new tools capable of multiple, inexpensive biomarker measurements on small samples of clinical tissue will become essential to the success of genetically informed and personalized cancer therapies...</description><pubDate>Wed, 04 Aug 2010 12:00:00 AM GMT</pubDate></item><item><title>Randox Release: Accurately And Efficiently Monitor The Performance Of HbA1c Assays  </title><link>http://www.biospace.com/news_story.aspx?StoryID=189404&amp;full=1</link><description>Crumlin, UK, 2nd August 2010 -- The American Diabetes Association, International Diabetes Federation and European Association for the Study of Diabetes consider HbA1c a more reliable indicator of long term diabetic control than blood glucose. &lt;/p&gt;&lt;p&gt;In order to have confidence in the patient results reported good quality control is essential.  A good control should be consistent over repeated analysis...</description><pubDate>Mon, 02 Aug 2010 12:00:00 AM GMT</pubDate></item><item><title>Radiology Practice Goes Digital with Intelerad Medical Systems Fully Integrated IntelePACS Solution  </title><link>http://www.businesswire.com/news/biospace2/20100803006708/en/Radiology-Practice-Digital-Intelerad%E2%80%99s-Fully-Integrated-IntelePACS</link><description>DENVER--(BUSINESS WIRE)--Intelerad Medical Systems, a leader in medical imaging PACS and workflow solutions, today announced that InHealth Imaging, LLC has chosen IntelePACS as their first filmless PACS system, including the IntelePACS Breast Imaging module.</description><pubDate>Mon, 02 Aug 2010 12:00:00 AM GMT</pubDate></item><item><title>Test Predicts Novartis AG's Kinase Inhibitor Resistance in CML, Hokkaido University Study  </title><link>http://www.reuters.com/article/idUSTRE66S0IH20100729</link><description>MedPage Today -- A novel laboratory test may accurately distinguish which chronic myeloid leukemia (CML) patients will develop resistance to imatinib (Gleevec), researchers said. </description><pubDate>Thu, 29 Jul 2010 12:00:00 AM GMT</pubDate></item></channel></rss>